Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer

benzinga.com/news/health-care/25/06/45999930/aptevo-therapeutics-touts-data-from-investigational-drug-trial-for-aggressive-blood-cancer

Aptevo Therapeutics Inc (NASDAQ:APVO) stock is surging on Wednesday.
As per data from Benzinga Pro, the stock is trading higher with a strong volume of 81.8 million compared to the average volume of 275.3k.
What Happened: Aptevo revealed new clinical data from its ongoing Phase 1b/2…

This story appeared on benzinga.com, 2025-06-18 15:37:43.
The Entire Business World on a Single Page. Free to Use →